Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy
Md Amir Hossain, Guilai Liu, Beiying Dai, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 156-201
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Meng‐Ling Wu, Qianrui Huang, Yao Xie, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 299
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4160-4160
Open Access | Times Cited: 106
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
Xianjing Chu, Wentao Tian, Ziqi Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 90
TME-Related Biomimetic Strategies Against Cancer
Cheng Peng, Yilin Xu, Jing Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 109-135
Open Access | Times Cited: 30
IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy
Yingmei Luo, Ze Chen, Mingjian Sun, et al.
Biomaterials (2021) Vol. 281, pp. 121341-121341
Closed Access | Times Cited: 73
Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
Chunjuan Jiang, Le Zhang, Xiaoping Xu, et al.
Advanced Science (2021) Vol. 8, Iss. 20
Open Access | Times Cited: 59
Tumor‐associated macrophages: An important player in breast cancer progression
Xinqun Huang, Jingsong Cao, Xuyu Zu
Thoracic Cancer (2021) Vol. 13, Iss. 3, pp. 269-276
Open Access | Times Cited: 58
CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
Wei Wei, Zhi‐Nan Chen, Ke Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12317-12317
Open Access | Times Cited: 40
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer
Runxian Wang, Zhenya Liu, Zhiyao Fan, et al.
Cancer Letters (2023) Vol. 567, pp. 216267-216267
Closed Access | Times Cited: 35
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 12
Research progress of copper-based metal–organic frameworks for cancer diagnosis and therapy
Xian Li, Zhifang Ma, Haozheng Wang, et al.
Coordination Chemistry Reviews (2024) Vol. 514, pp. 215943-215943
Closed Access | Times Cited: 11
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi‐Xun Yan, Yan Dong, Q. L. Niu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Normalization in tumor ecosystem: Opportunities and challenges
Keywan Mortezaee
Cell Biology International (2021) Vol. 45, Iss. 10, pp. 2017-2030
Closed Access | Times Cited: 42
Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy
Kunjing Liu, Qi Sun, Qi Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113618-113618
Open Access | Times Cited: 34
STING activation in macrophages by vanillic acid exhibits antineoplastic potential
Man Zhu, Xiaoyu Tang, Zeren Zhu, et al.
Biochemical Pharmacology (2023) Vol. 213, pp. 115618-115618
Closed Access | Times Cited: 22
Macrophage’s role in solid tumors: two edges of a sword
Arian Jahandideh, Mahsa Yarizadeh, Maryam Noei-Khesht Masjedi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21
A promising target for breast cancer: B7-H3
Ying Jiang, Jiayu Liu, Lingyan Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS–STING pathway activation
Yijia Wu, Yao Lin, Feiyang Shen, et al.
Neoplasia (2024) Vol. 49, pp. 100973-100973
Open Access | Times Cited: 5
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
Xiao‐Dong Mo, Weilong Zhang, Guomei Fu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2309-2322
Closed Access | Times Cited: 5
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
Chunyi Shen, Zhen Zhang, Yonggui Tian, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers
Yingfang Feng, Meng Gao, Xiyue Xu, et al.
European Journal of Cancer (2024) Vol. 213, pp. 115069-115069
Closed Access | Times Cited: 4
Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11
Ling Li, Manzhi Zhao, Marjan van Meurs, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Programmed cell death-related prognostic genes mediate dysregulation of the immune microenvironment in triple-negative breast cancer
Xiaowen Ma, Hui Shan, Chen Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting T-cell Aging to Remodel the Aging Immune System and Revitalize Geriatric Immunotherapy
Chen Mi, Su Zhou, Jianxin Xue
Aging and Disease (2025)
Open Access
PD-L1 Palmitoylation by ZDHHC3 Contributes to Chemoresistance and Inhibits CD8+ T Cell Cytotoxicity in Gastric Cancer
Hui Li, Lin Zhu, Hongmin Wang
International Journal of Pharmacology (2025) Vol. 21, Iss. 2, pp. 259-269
Closed Access
Page 1 - Next Page

Scroll to top